Anteris Technologies Global (NASDAQ:AVR) Reaches New 52-Week High – Still a Buy?

Posted by Brenda Bartman on May 14th, 2026

Anteris Technologies Global Corp. (NASDAQ:AVR – Get Free Report) reached a new 52-week high on Thursday . The company traded as high as $7.10 and last traded at $7.05, with a volume of 327708 shares trading hands. The stock had previously closed at $6.53.

Wall Street Analyst Weigh In

Several analysts recently issued reports on AVR shares. Lake Street Capital reiterated a “buy” rating and set a $15.00 price target on shares of Anteris Technologies Global in a research report on Friday, January 23rd. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $15.00 price target on shares of Anteris Technologies Global in a report on Friday, March 27th. Finally, Wells Fargo & Company initiated coverage on shares of Anteris Technologies Global in a research note on Wednesday, March 11th. They set an “overweight” rating and a $16.00 price target for the company. Three investment analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, Anteris Technologies Global has an average rating of “Moderate Buy” and an average price target of $15.33.

Read Our Latest Report on AVR

Anteris Technologies Global Trading Up 11.0%

The stock has a market capitalization of $704.92 million, a PE ratio of -3.24 and a beta of 1.32. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.01. The firm has a 50 day moving average price of $5.92 and a 200 day moving average price of $5.33.

Anteris Technologies Global (NASDAQ:AVR – Get Free Report) last released its quarterly earnings results on Tuesday, May 12th. The company reported ($0.28) EPS for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.01). Anteris Technologies Global had a negative net margin of 5,148.78% and a negative return on equity of 1,053.55%. The company had revenue of $0.49 million during the quarter, compared to analysts’ expectations of $0.77 million. During the same period in the previous year, the company posted ($0.61) earnings per share. Equities analysts expect that Anteris Technologies Global Corp. will post -1.54 EPS for the current fiscal year.

Institutional Trading of Anteris Technologies Global

A number of hedge funds have recently bought and sold shares of AVR. Deutsche Bank AG boosted its position in Anteris Technologies Global by 8.1% in the fourth quarter. Deutsche Bank AG now owns 28,865 shares of the company’s stock worth $144,000 after purchasing an additional 2,171 shares during the last quarter. Bank of America Corp DE boosted its holdings in shares of Anteris Technologies Global by 35.7% in the 3rd quarter. Bank of America Corp DE now owns 10,631 shares of the company’s stock worth $48,000 after buying an additional 2,798 shares during the last quarter. Russell Investments Group Ltd. grew its position in Anteris Technologies Global by 76.9% during the third quarter. Russell Investments Group Ltd. now owns 6,536 shares of the company’s stock valued at $29,000 after buying an additional 2,841 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in Anteris Technologies Global by 35.2% during the second quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 11,744 shares of the company’s stock worth $45,000 after buying an additional 3,055 shares during the last quarter. Finally, Barclays PLC raised its position in Anteris Technologies Global by 3.0% in the fourth quarter. Barclays PLC now owns 148,128 shares of the company’s stock worth $739,000 after acquiring an additional 4,289 shares during the period.

Anteris Technologies Global Company Profile

(Get Free Report)

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.